ScholarLens Back to search
2010•Annals of the Rheumatic DiseasesOpen access

The early marginal zone B cell initiated T independent type 2 response resists the proteasome inhibitor bortezomib

Veronika Lang, Dirk Mielenz, Hans‐Martin Jäck, Kirsten Neubert, Christian Böhm, Georg Schett, Reinhard Voll, Silke Meister

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Bortezomib, Proteasome inhibitor, Medicine, Multiple myeloma, Proteasome, Immunology, Plasma cell, Marginal zone

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The early marginal zone B cell initiated T independent type 2 response resists the proteasome inhibitor bortezomib — Research Paper | ScholarLens